DXN Holdings Bhd.

KLSE:DXN Stock Report

Market Cap: RM 2.4b

DXN Holdings Bhd Valuation

Is DXN undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of DXN when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: DXN (MYR0.49) is trading below our estimate of fair value (MYR1.47)

Significantly Below Fair Value: DXN is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for DXN?

Key metric: As DXN is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for DXN. This is calculated by dividing DXN's market cap by their current earnings.
What is DXN's PE Ratio?
PE Ratio7.9x
EarningsRM 308.91m
Market CapRM 2.44b

Price to Earnings Ratio vs Peers

How does DXN's PE Ratio compare to its peers?

The above table shows the PE ratio for DXN vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average33.4x
KAREX Karex Berhad
48.4x39.6%RM 953.4m
SUNZEN Sunzen Biotech Berhad
40.1xn/aRM 241.9m
NOVA Nova Wellness Group Berhad
20.1x25.6%RM 140.2m
W7L Warpaint London
25x11.8%UK£427.6m
DXN DXN Holdings Bhd
7.9x14.9%RM 2.4b

Price-To-Earnings vs Peers: DXN is good value based on its Price-To-Earnings Ratio (7.9x) compared to the peer average (33.4x).

Price to Earnings Ratio vs Industry

How does DXN's PE Ratio compare vs other companies in the Asian Personal Products Industry?

5 CompaniesPrice / EarningsEstimated GrowthMarket Cap
DXN 7.9xIndustry Avg. 24.6xNo. of Companies24PE020406080100+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Earnings vs Industry: DXN is good value based on its Price-To-Earnings Ratio (7.9x) compared to the Asian Personal Products industry average (24.6x).

Price to Earnings Ratio vs Fair Ratio

What is DXN's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

DXN PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio7.9x
Fair PE Ratio19.1x

Price-To-Earnings vs Fair Ratio: DXN is good value based on its Price-To-Earnings Ratio (7.9x) compared to the estimated Fair Price-To-Earnings Ratio (19.1x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst DXN forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
CurrentRM 0.49
RM 0.86
+76.0%
5.1%RM 0.92RM 0.80n/a4
Nov ’25RM 0.56
RM 0.87
+54.4%
3.6%RM 0.92RM 0.84n/a4
Oct ’25RM 0.60
RM 0.89
+46.7%
4.2%RM 0.93RM 0.85n/a4
Sep ’25RM 0.62
RM 0.89
+43.1%
4.2%RM 0.93RM 0.85n/a4
Aug ’25RM 0.65
RM 0.89
+37.1%
4.1%RM 0.93RM 0.85n/a4
Jul ’25RM 0.64
RM 0.90
+41.4%
3.5%RM 0.93RM 0.86n/a3
Jun ’25RM 0.64
RM 0.90
+42.3%
3.4%RM 0.93RM 0.86n/a3
May ’25RM 0.63
RM 0.90
+44.5%
3.4%RM 0.93RM 0.86n/a3
Apr ’25RM 0.61
RM 0.89
+44.9%
3.3%RM 0.93RM 0.86n/a3
Mar ’25RM 0.63
RM 0.89
+41.3%
3.3%RM 0.93RM 0.86n/a3
Feb ’25RM 0.66
RM 0.88
+34.4%
3.5%RM 0.93RM 0.85n/a4
Jan ’25RM 0.64
RM 0.89
+40.2%
3.3%RM 0.93RM 0.85n/a4
Dec ’24RM 0.66
RM 0.89
+35.9%
3.3%RM 0.93RM 0.85n/a4
Nov ’24RM 0.67
RM 0.90
+35.8%
2.3%RM 0.93RM 0.88RM 0.563
Oct ’24RM 0.68
RM 0.90
+32.9%
2.3%RM 0.93RM 0.88RM 0.603
Sep ’24RM 0.69
RM 0.90
+30.0%
2.3%RM 0.93RM 0.88RM 0.623
Aug ’24RM 0.74
RM 0.90
+22.1%
2.3%RM 0.93RM 0.88RM 0.653

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.

Discover undervalued companies

Nova Wellness Group Berhad

RM 140.2m

Develops, produces, and sells nutraceutical and skincare products in Malaysia and internationally.

NOVA

RM 0.44

7D

-4.3%

1Y

-30.2%